Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Homeobox protein Hox-D1 (HOXD1) is a nuclear transcription factor belonging to the Antennapedia homeobox family, encoded by the HOXD1 gene. It plays a critical role in establishing positional identity along the anterior-posterior body axis and is involved in embryonic differentiation and limb development. The HOXD1 protein contains a highly-con-served homeodomain responsible for sequence-specific DNA binding, acting as a master regulator during early development. Mutations or altered expression in HOXD1 are associated with significant developmental abnormalities and may have cancer-inhibiting properties[1][3][4][6]. HOXD1 is not a therapeutic target for any current drugs[3][7], but experimental studies in animals implicate its role in migration and differentiation of neural crest cells and regulation of genes related to cell motility and the epithelial-mesenchymal transition[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homeobox protein Hox-D1 (HOXD1).